We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SNX8 is not prognostic in Ovary Serous Cystadenocarcinoma (TCGA)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
13.1
Number of samples
349
Samples
Sample
Description
TPM
TCGA-24-1847-01A
0 years, female, white, stage:Stage IV, alive, 343 days
40.7
TCGA-57-1585-01A
0 years, female, white, stage:Stage IIIC, dead, 53 days
40.6
TCGA-61-1733-01A
0 years, female, white, stage:Stage IIIC, alive, 967 days
36.9
TCGA-25-1627-01A
0 years, female, white, stage:Stage IIIC, dead, 394 days
36.8
TCGA-23-1123-01A
0 years, female, white, stage:Stage IIIC, dead, 1018 days
35.9
TCGA-61-2104-01A
0 years, female, white, stage:Stage IIC, alive, 2338 days
34.9
TCGA-57-1584-01A
0 years, female, white, stage:Stage IIIC, alive, 643 days
32.1
TCGA-61-2003-01A
0 years, female, white, stage:Stage IIIC, alive, 122 days
31.6
TCGA-23-1809-01A
0 years, female, white, stage:Stage IIC, alive, 16 days
31.4
TCGA-24-2290-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
31.2
TCGA-36-1574-01A
0 years, female, asian, stage:Stage IIIC, alive, 686 days
29.4
TCGA-09-2051-01A
0 years, female, white, stage:Stage IIIC, alive, 1919 days
29.3
TCGA-13-1405-01A
0 years, female, white, stage:Stage IV, dead, 868 days
28.9
TCGA-31-1946-01A
0 years, female, stage:Stage IIIC, alive, 918 days
28.9
TCGA-61-2113-01A
0 years, female, white, stage:Stage IIC, dead, 676 days
28.8
TCGA-31-1956-01A
0 years, female, white, stage:Stage IIIB, alive, 1342 days
28.5
TCGA-61-2012-01A
0 years, female, white, stage:Stage IIC, alive, 932 days
26.7
TCGA-25-2398-01A
0 years, female, white, stage:Stage IIIC, dead, 1369 days
26.4
TCGA-61-2102-01A
0 years, female, white, stage:Stage IIIC, dead, 197 days
26.2
TCGA-25-1320-01A
0 years, female, white, stage:Stage IIIC, dead, 1155 days
26.1
TCGA-24-1558-01A
0 years, female, white, stage:Stage IIIC, dead, 594 days
25.8
TCGA-24-1417-01A
0 years, female, white, stage:Stage IV, alive, 238 days
25.5
TCGA-30-1861-01A
0 years, female, white, stage:Stage IIIC, dead, 1058 days
24.5
TCGA-24-2289-01A
0 years, female, white, stage:Stage IV, dead, 2049 days
24.4
TCGA-25-2409-01A
0 years, female, white, stage:Stage IV, dead, 821 days
24.1
TCGA-61-1995-01A
0 years, female, white, stage:Stage IIIC, alive, 61 days
23.7
TCGA-24-1553-01A
0 years, female, white, stage:Stage IIIB, dead, 1767 days
23.7
TCGA-31-1959-01A
0 years, female, white, stage:Stage IV, alive, 67 days
23.7
TCGA-24-1850-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
23.7
TCGA-24-1603-01A
0 years, female, white, stage:Stage IIIB, dead, 2742 days
23.7
TCGA-09-0369-01A
0 years, female, white, stage:Stage IIIC, dead, 1082 days
23.1
TCGA-59-2348-01A
0 years, female, white, stage:Stage IIIC, alive, 5481 days
23.1
TCGA-13-0720-01A
0 years, female, white, stage:Stage IIIC, dead, 1355 days
22.2
TCGA-24-1427-01A
0 years, female, stage:Stage IIIC, alive, 147 days
22.1
TCGA-24-1424-01A
0 years, female, white, stage:Stage IIIC, alive, 183 days
22.0
TCGA-23-2077-01A
0 years, female, white, stage:Stage IIIC, alive, 3525 days
22.0
TCGA-24-2293-01A
0 years, female, white, stage:'--, dead, 506 days
21.9
TCGA-25-1870-01A
0 years, female, white, stage:Stage IIIC, dead, 455 days
21.9
TCGA-31-1953-01A
0 years, female, asian, stage:Stage IIIC, alive, 204 days
21.8
TCGA-09-2054-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 637 days
21.8
TCGA-24-2036-01A
0 years, female, white, stage:Stage IIIA, dead, 1947 days
21.7
TCGA-20-0987-01A
0 years, female, white, stage:Stage IIIC, dead, 701 days
21.6
TCGA-24-1428-01A
0 years, female, white, stage:Stage IIIC, alive, 529 days
21.5
TCGA-31-1951-01A
0 years, female, white, stage:Stage IIIC, alive, 684 days
21.5
TCGA-13-1411-01A
0 years, female, white, stage:Stage IIIC, dead, 531 days
21.4
TCGA-36-1576-01A
0 years, female, stage:Stage IIIC, alive, 915 days
21.4
TCGA-29-1694-01A
0 years, female, white, stage:Stage IIIC, dead, 1187 days
21.4
TCGA-61-1918-01A
0 years, female, white, stage:Stage IV, dead, 479 days
21.2
TCGA-36-1569-01A
0 years, female, white, stage:Stage IIIC, alive, 885 days
21.1
TCGA-61-2101-01A
0 years, female, white, stage:Stage IIIC, dead, 1688 days
21.0
TCGA-25-1313-01A
0 years, female, white, stage:Stage IV, dead, 820 days
20.9
TCGA-24-1423-01A
0 years, female, white, stage:Stage IIIC, alive, 190 days
20.8
TCGA-25-1322-01A
0 years, female, white, stage:Stage IV, dead, 91 days
20.4
TCGA-31-1950-01A
0 years, female, white, stage:Stage IIIC, alive, 571 days
20.1
TCGA-29-1785-01A
0 years, female, white, stage:Stage IIIC, dead, 1104 days
20.0
TCGA-25-1326-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
19.7
TCGA-29-1693-01A
0 years, female, white, stage:Stage IIIC, alive, 3096 days
19.6
TCGA-31-1944-01A
0 years, female, white, stage:Stage IIIC, alive, 1386 days
19.5
TCGA-24-2023-01A
0 years, female, white, stage:Stage IIIA, dead, 1364 days
19.3
TCGA-23-1111-01A
0 years, female, white, stage:Stage IIIC, alive, 98 days
19.0
TCGA-25-1626-01A
0 years, female, white, stage:Stage IIIC, dead, 518 days
18.9
TCGA-24-1434-01A
0 years, female, white, stage:Stage IIIC, dead, 568 days
18.8
TCGA-61-2088-01A
0 years, female, white, stage:Stage IIIC, alive, 145 days
18.7
TCGA-25-1628-01A
0 years, female, white, stage:Stage IIIC, dead, 627 days
18.7
TCGA-13-1410-01A
0 years, female, white, stage:Stage IV, alive, 2464 days
18.7
TCGA-09-1662-01A
0 years, female, white, stage:Stage IV, dead, 2717 days
18.4
TCGA-24-2026-01A
0 years, female, white, stage:Stage IIIC, dead, 1059 days
18.4
TCGA-25-2404-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 883 days
18.4
TCGA-36-1580-01A
0 years, female, stage:Stage IIIC, dead, 737 days
18.2
TCGA-13-1512-01A
0 years, female, white, stage:Stage IIIC, alive, 442 days
18.0
TCGA-24-2271-01A
0 years, female, asian, stage:Stage IIIC, dead, 962 days
18.0
TCGA-13-0726-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
17.9
TCGA-24-1419-01A
0 years, female, white, stage:Stage IIIC, alive, 239 days
17.8
TCGA-24-1552-01A
0 years, female, white, stage:Stage IIIC, dead, 1259 days
17.7
TCGA-13-1507-01A
0 years, female, white, stage:Stage IIIC, dead, 1993 days
17.7
TCGA-24-1550-01A
0 years, female, white, stage:Stage IIIC, dead, 1249 days
17.6
TCGA-29-1710-01A
0 years, female, white, stage:Stage IIIC, dead, 951 days
17.4
TCGA-24-1418-01A
0 years, female, white, stage:Stage IIIC, alive, 243 days
17.4
TCGA-29-1783-01A
0 years, female, white, stage:Stage IIIC, alive, 220 days
17.1
TCGA-24-1842-01A
0 years, female, white, stage:Stage IIIC, alive, 253 days
17.0
TCGA-59-2355-01A
0 years, female, white, stage:Stage IV, dead, 65 days
16.9
TCGA-24-1430-01A
0 years, female, white, stage:Stage IIIC, dead, 863 days
16.8
TCGA-25-2042-01A
0 years, female, american indian or alaska native, stage:Stage IIIC, dead, 396 days
16.7
TCGA-13-1407-01A
0 years, female, white, stage:Stage IIIC, alive, 2534 days
16.6
TCGA-24-2035-01A
0 years, female, white, stage:Stage IIIC, dead, 857 days
16.6
TCGA-25-1323-01A
0 years, female, white, stage:Stage IIIC, dead, 395 days
16.5
TCGA-36-1577-01A
0 years, female, asian, stage:Stage IIC, alive, 783 days
16.5
TCGA-25-2392-01A
0 years, female, white, stage:Stage IV, dead, 31 days
16.4
TCGA-13-0730-01A
0 years, female, white, stage:Stage IIIC, dead, 542 days
16.2
TCGA-09-0367-01A
0 years, female, native hawaiian or other pacific islander, stage:Stage IIIC, dead, 547 days
16.2
TCGA-13-0897-01A
0 years, female, white, stage:Stage IIIC, dead, 2182 days
16.1
TCGA-04-1542-01A
0 years, female, white, stage:Stage IIIB, dead, 2561 days
16.1
TCGA-13-0920-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
16.1
TCGA-61-1919-01A
0 years, female, white, stage:Stage IIIC, dead, 1161 days
16.0
TCGA-24-1563-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1451 days
16.0
TCGA-24-2261-01A
0 years, female, white, stage:Stage IIIC, dead, 24 days
15.9
TCGA-25-1318-01A
0 years, female, white, stage:Stage IIIC, dead, 1064 days
15.8
TCGA-24-1928-01A
0 years, female, white, stage:Stage IIIC, dead, 336 days
15.7
TCGA-04-1365-01A
0 years, female, white, stage:Stage IIIB, alive, 947 days
15.6
TCGA-23-2078-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
15.6
TCGA-29-1762-01A
0 years, female, white, stage:Stage IV, dead, 2634 days
15.6
TCGA-24-1467-01A
0 years, female, white, stage:Stage IIIC, dead, 3224 days
15.6
TCGA-23-1116-01A
0 years, female, white, stage:Stage IIIC, dead, 592 days
15.5
TCGA-61-2002-01A
0 years, female, white, stage:Stage IIIC, alive, 547 days
15.4
TCGA-13-0911-01A
0 years, female, white, stage:Stage IV, dead, 1355 days
15.4
TCGA-24-1103-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1646 days
15.3
TCGA-04-1648-01A
0 years, female, white, stage:Stage IIIC, dead, 871 days
15.3
TCGA-61-2097-01A
0 years, female, white, stage:Stage IIC, alive, 1844 days
15.2
TCGA-13-1404-01A
0 years, female, white, stage:Stage IIIC, alive, 2469 days
15.0
TCGA-13-1403-01A
0 years, female, white, stage:Stage IIIC, dead, 2345 days
15.0
TCGA-24-1431-01A
0 years, female, white, stage:Stage IIIC, dead, 583 days
14.9
TCGA-25-2401-01A
0 years, female, white, stage:Stage IIIC, dead, 90 days
14.8
TCGA-13-0883-01A
0 years, female, white, stage:Stage IIIC, dead, 2097 days
14.7
TCGA-29-1763-01A
0 years, female, black or african american, stage:Stage IIC, alive, 2032 days
14.7
TCGA-24-1549-01A
0 years, female, white, stage:Stage IIIB, dead, 1721 days
14.7
TCGA-23-1118-01A
0 years, female, white, stage:Stage IIIC, alive, 2616 days
14.6
TCGA-61-2000-01A
0 years, female, white, stage:Stage IIIC, alive, 441 days
14.6
TCGA-25-1329-01A
0 years, female, white, stage:Stage IIIC, dead, 457 days
14.6
TCGA-61-1998-01A
0 years, female, white, stage:Stage IIIC, alive, 168 days
14.5
TCGA-13-1483-01A
0 years, female, white, stage:Stage IIIC, dead, 895 days
14.4
TCGA-20-1682-01A
0 years, female, white, stage:Stage IIIC, alive, 837 days
14.4
TCGA-24-2288-01A
0 years, female, white, stage:Stage IIIC, dead, 25 days
14.4
TCGA-59-2354-01A
0 years, female, white, stage:Stage IIIC, dead, 1046 days
14.3
TCGA-25-1630-01A
0 years, female, white, stage:Stage IIIC, dead, 1162 days
14.2
TCGA-13-1492-01A
0 years, female, white, stage:Stage IIIC, dead, 3819 days
14.2
TCGA-13-1408-01A
0 years, female, white, stage:Stage IIIC, dead, 1680 days
14.2
TCGA-29-2428-01A
0 years, female, white, stage:Stage IIIC, alive, 1372 days
14.2
TCGA-24-2024-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1769 days
14.1
TCGA-24-1435-01A
0 years, female, white, stage:Stage IIIC, dead, 1324 days
14.1
TCGA-25-1328-01A
0 years, female, white, stage:Stage IIIC, dead, 2009 days
14.0
TCGA-61-2098-01A
0 years, female, white, stage:Stage IIIC, alive, 1993 days
14.0
TCGA-59-2350-01A
0 years, female, stage:Stage IV, dead, 679 days
13.8
TCGA-29-2427-01A
0 years, female, white, stage:Stage IIIC, alive, 1900 days
13.8
TCGA-24-1604-01A
0 years, female, white, stage:Stage IIIC, dead, 2688 days
13.8
TCGA-09-0366-01A
0 years, female, white, stage:Stage IIIC, dead, 1757 days
13.8
TCGA-29-1776-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 360 days
13.7
TCGA-24-1551-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
13.7
TCGA-29-1703-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1815 days
13.7
TCGA-61-1724-01A
0 years, female, white, stage:Stage IIIC, dead, 637 days
13.6
TCGA-24-1924-01A
0 years, female, white, stage:Stage IIIC, dead, 919 days
13.5
TCGA-25-1635-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
13.4
TCGA-61-1728-01A
0 years, female, white, stage:Stage IV, alive, 848 days
13.3
TCGA-13-1511-01A
0 years, female, asian, stage:Stage IV, dead, 1650 days
13.3
TCGA-24-1469-01A
0 years, female, white, stage:Stage IIIC, alive, 277 days
13.2
TCGA-13-1489-01A
0 years, female, white, stage:Stage IIIC, dead, 2553 days
13.1
TCGA-24-1562-01A
0 years, female, white, stage:Stage IIIC, dead, 1384 days
13.1
TCGA-59-A5PD-01A
0 years, female, black or african american, stage:Stage IC, dead, 624 days
13.0
TCGA-29-1695-01A
0 years, female, white, stage:Stage IIIC, dead, 1229 days
13.0
TCGA-30-1860-01A
0 years, female, white, stage:Stage IIIC, dead, 1366 days
13.0
TCGA-24-2020-01A
0 years, female, white, stage:Stage IIIC, dead, 4624 days
13.0
TCGA-29-1761-01A
0 years, female, asian, stage:Stage IIIC, dead, 528 days
12.9
TCGA-24-2254-01A
0 years, female, white, stage:Stage IIIC, dead, 1736 days
12.8
TCGA-24-1105-01A
0 years, female, white, stage:Stage IIIC, dead, 1442 days
12.8
TCGA-61-1741-01A
0 years, female, white, stage:Stage IIIB, dead, 1024 days
12.6
TCGA-09-2048-01A
0 years, female, white, stage:Stage IIIC, dead, 138 days
12.6
TCGA-20-1687-01A
0 years, female, white, stage:Stage IV, alive, 81 days
12.6
TCGA-13-2060-01A
0 years, female, white, stage:Stage IV, alive, 2369 days
12.5
TCGA-36-1581-01A
0 years, female, white, stage:Stage IIC, alive, 751 days
12.5
TCGA-61-1900-01A
0 years, female, black or african american, stage:Stage IIIB, alive, 176 days
12.5
TCGA-24-1846-01A
0 years, female, stage:Stage IIIC, alive, 133 days
12.4
TCGA-24-1425-01A
0 years, female, white, stage:Stage IIIC, alive, 181 days
12.3
TCGA-23-2084-01A
0 years, female, white, stage:Stage IV, dead, 1516 days
12.3
TCGA-23-1023-01A
0 years, female, white, stage:Stage IIIC, alive, 1233 days
12.2
TCGA-25-1877-01A
0 years, female, white, stage:Stage IIIC, dead, 730 days
12.2
TCGA-25-2399-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
12.1
TCGA-13-1497-01A
0 years, female, white, stage:Stage IIIC, alive, 3871 days
12.1
TCGA-25-1631-01A
0 years, female, white, stage:Stage IIIC, dead, 9 days
12.0
TCGA-24-2027-01A
0 years, female, white, stage:Stage IV, dead, 3337 days
11.9
TCGA-20-0991-01A
0 years, female, white, stage:Stage IIB, alive, 797 days
11.9
TCGA-09-1670-01A
0 years, female, white, stage:Stage IIIA, alive, 547 days
11.8
TCGA-29-1691-01A
0 years, female, white, stage:Stage IIIC, dead, 1470 days
11.7
TCGA-25-1312-01A
0 years, female, white, stage:Stage IV, dead, 31 days
11.7
TCGA-13-0924-01A
0 years, female, white, stage:Stage IV, alive, 2614 days
11.7
TCGA-20-1683-01A
0 years, female, white, stage:Stage IIIC, alive, 772 days
11.7
TCGA-57-1993-01A
0 years, female, white, stage:Stage IIIC, alive, 763 days
11.7
TCGA-04-1364-01A
0 years, female, white, stage:Stage IIIC, dead, 1024 days
11.6
TCGA-24-2033-01A
0 years, female, white, stage:Stage IIIC, dead, 562 days
11.6
TCGA-24-1567-01A
0 years, female, white, stage:Stage IIIB, dead, 524 days
11.6
TCGA-24-2297-01A
0 years, female, white, stage:Stage IIIC, dead, 1699 days
11.5
TCGA-25-1321-01A
0 years, female, white, stage:Stage IIIC, dead, 1033 days
11.5
TCGA-24-1474-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 676 days
11.5
TCGA-25-1316-01A
0 years, female, white, stage:Stage IIIC, dead, 1279 days
11.5
TCGA-13-1496-01A
0 years, female, white, stage:Stage IIIC, dead, 129 days
11.5
TCGA-13-1485-01A
0 years, female, white, stage:Stage IV, dead, 629 days
11.4
TCGA-04-1343-01A
0 years, female, white, stage:Stage IV, dead, 361 days
11.3
TCGA-24-2267-01A
0 years, female, white, stage:Stage IIB, dead, 1446 days
11.3
TCGA-23-1024-01A
0 years, female, white, stage:Stage IV, alive, 468 days
11.2
TCGA-24-0968-01A
0 years, female, white, stage:Stage IIIC, dead, 598 days
11.1
TCGA-09-1669-01A
0 years, female, white, stage:Stage IIIA, alive, 928 days
11.1
TCGA-61-1725-01A
0 years, female, white, stage:Stage IIIC, alive, 956 days
11.0
TCGA-24-2280-01A
0 years, female, white, stage:Stage IIIC, alive, 2143 days
10.9
TCGA-13-1506-01A
0 years, female, white, stage:Stage IIIC, dead, 1039 days
10.9
TCGA-24-1422-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 23 days
10.9
TCGA-13-0797-01A
0 years, female, white, stage:Stage IIIC, alive, 2121 days
10.9
TCGA-24-1557-01A
0 years, female, white, stage:Stage IIIC, dead, 1213 days
10.8
TCGA-61-1907-01A
0 years, female, white, stage:Stage IIIC, alive, 952 days
10.8
TCGA-24-1426-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
10.8
TCGA-29-1701-01A
0 years, female, white, stage:Stage IIIC, dead, 515 days
10.8
TCGA-30-1862-01A
0 years, female, white, stage:Stage IV, dead, 186 days
10.7
TCGA-04-1362-01A
0 years, female, white, stage:Stage IIC, dead, 1348 days
10.7
TCGA-61-2111-01A
0 years, female, white, stage:Stage IV, alive, 3825 days
10.6
TCGA-25-1623-01A
0 years, female, white, stage:Stage IV, dead, 565 days
10.5
TCGA-61-2008-01A
0 years, female, asian, stage:Stage IIC, alive, 932 days
10.5
TCGA-09-0364-01A
0 years, female, white, stage:Stage IIC, dead, 887 days
10.5
TCGA-13-0765-01A
0 years, female, white, stage:Stage IIIC, dead, 1389 days
10.4
TCGA-30-1891-01A
0 years, female, white, stage:Stage IIIC, dead, 914 days
10.3
TCGA-25-1319-01A
0 years, female, white, stage:Stage IIIC, dead, 1977 days
10.3
TCGA-13-1495-01A
0 years, female, white, stage:Stage IIIC, dead, 2749 days
10.2
TCGA-25-2393-01A
0 years, female, white, stage:Stage IIIC, dead, 1157 days
10.2
TCGA-24-1844-01A
0 years, female, white, stage:Stage IIIC, alive, 113 days
10.2
TCGA-23-1027-01A
0 years, female, white, stage:Stage IIIC, dead, 976 days
10.2
TCGA-61-1911-01A
0 years, female, white, stage:Stage IIA, alive, 1293 days
10.2
TCGA-36-1571-01A
0 years, female, white, stage:Stage IIIB, dead, 695 days
10.2
TCGA-61-1737-01A
0 years, female, white, stage:Stage IV, alive, 1364 days
10.2
TCGA-29-1705-01A
0 years, female, white, stage:Stage IIIC, dead, 555 days
10.1
TCGA-25-2396-01A
0 years, female, white, stage:Stage IIIC, dead, 92 days
10.1
TCGA-13-0795-01A
0 years, female, white, stage:Stage IIIC, dead, 619 days
10.0
TCGA-25-1633-01A
0 years, female, white, stage:Stage IIIC, dead, 1891 days
10.0
TCGA-25-1315-01A
0 years, female, white, stage:Stage IIIC, dead, 1583 days
10.0
TCGA-13-0725-01A
0 years, female, white, stage:Stage IIIC, dead, 377 days
9.9
TCGA-24-1923-01A
0 years, female, white, stage:Stage IIIC, dead, 690 days
9.9
TCGA-29-A5NZ-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1088 days
9.8
TCGA-13-0916-01A
0 years, female, white, stage:Stage IIIC, alive, 1785 days
9.8
TCGA-23-1109-01A
0 years, female, white, stage:Stage IIIC, dead, 1562 days
9.8
TCGA-24-2281-01A
0 years, female, white, stage:Stage IIA, alive, 1357 days
9.7
TCGA-30-1857-01A
0 years, female, white, stage:Stage IV, dead, 8 days
9.6
TCGA-24-0966-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 232 days
9.5
TCGA-13-1498-01A
0 years, female, white, stage:Stage IIIC, dead, 2012 days
9.5
TCGA-23-1030-01A
0 years, female, white, stage:Stage IIIC, alive, 886 days
9.4
TCGA-13-0766-01A
0 years, female, white, stage:Stage IIIC, dead, 1725 days
9.4
TCGA-36-1568-01A
0 years, female, stage:Stage IIIC, alive, 875 days
9.4
TCGA-57-1994-01A
0 years, female, white, stage:'--, alive, 761 days
9.3
TCGA-24-1464-01A
0 years, female, white, stage:Stage IIIC, dead, 379 days
9.3
TCGA-30-1853-01A
0 years, female, white, stage:Stage IIIC, dead, 1103 days
9.2
TCGA-29-1770-01A
0 years, female, white, stage:Stage IIIC, alive, 741 days
9.2
TCGA-13-0804-01A
0 years, female, white, stage:Stage IIIC, dead, 1073 days
9.1
TCGA-24-1546-01A
0 years, female, white, stage:Stage IIIC, dead, 1955 days
9.1
TCGA-29-2425-01A
0 years, female, white, stage:Stage IIIC, alive, 1977 days
9.1
TCGA-13-0923-01A
0 years, female, white, stage:Stage IIIC, alive, 2547 days
9.0
TCGA-04-1514-01A
0 years, female, white, stage:Stage IIIA, dead, 1720 days
9.0
TCGA-61-1914-01A
0 years, female, stage:Stage IIIC, alive, 1722 days
9.0
TCGA-29-1697-01A
0 years, female, white, stage:Stage IIIC, dead, 949 days
8.9
TCGA-13-1505-01A
0 years, female, white, stage:Stage IIIC, alive, 1998 days
8.9
TCGA-24-2298-01A
0 years, female, white, stage:Stage IIIC, dead, 1620 days
8.9
TCGA-04-1361-01A
0 years, female, white, stage:Stage IIIB, alive, 989 days
8.8
TCGA-29-1696-01A
0 years, female, white, stage:Stage IIIC, dead, 1032 days
8.8
TCGA-24-1560-01A
0 years, female, white, stage:Stage IIIC, dead, 1341 days
8.8
TCGA-29-1711-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 1053 days
8.7
TCGA-29-1690-01A
0 years, female, white, stage:Stage IIIC, dead, 1448 days
8.6
TCGA-25-1317-01A
0 years, female, white, stage:Stage IIIC, dead, 61 days
8.6
TCGA-13-1477-01A
0 years, female, white, stage:Stage IV, dead, 1662 days
8.6
TCGA-04-1655-01A
0 years, female, white, stage:Stage IIIB, dead, 1380 days
8.6
TCGA-13-0885-01A
0 years, female, white, stage:Stage IIIC, alive, 3388 days
8.5
TCGA-04-1331-01A
0 years, female, white, stage:Stage IIIC, dead, 1336 days
8.5
TCGA-25-1634-01A
0 years, female, white, stage:Stage IIIC, dead, 1091 days
8.5
TCGA-25-1632-01A
0 years, female, white, stage:Stage IV, dead, 1799 days
8.5
TCGA-61-1721-01A
0 years, female, white, stage:Stage IV, alive, 338 days
8.4
TCGA-57-1582-01A
0 years, female, white, stage:Stage IIIC, dead, 731 days
8.4
TCGA-61-2109-01A
0 years, female, white, stage:Stage IIIC, dead, 629 days
8.4
TCGA-24-1416-01A
0 years, female, white, stage:Stage IV, alive, 194 days
8.3
TCGA-5X-AA5U-01A
0 years, female, black or african american, stage:Stage IIC, alive, 361 days
8.2
TCGA-24-0979-01A
0 years, female, white, stage:Stage IV, dead, 1264 days
8.2
TCGA-24-1843-01A
0 years, female, white, stage:Stage IIIC, alive, 106 days
8.2
TCGA-24-2038-01A
0 years, female, white, stage:Stage IIIA, dead, 1354 days
8.2
TCGA-23-1120-01A
0 years, female, white, stage:Stage IIIC, alive, 130 days
8.1
TCGA-29-1768-01A
0 years, female, white, stage:Stage IV, dead, 952 days
8.0
TCGA-09-2045-01A
0 years, female, asian, stage:Stage IV, dead, 1069 days
7.9
TCGA-13-1509-01A
0 years, female, white, stage:Stage IV, alive, 2438 days
7.9
TCGA-61-2009-01A
0 years, female, white, stage:Stage IIIC, alive, 1212 days
7.9
TCGA-61-2110-01A
0 years, female, white, stage:Stage IIIC, dead, 1354 days
7.8
TCGA-09-1673-01A
0 years, female, white, stage:Stage IV, alive, 92 days
7.8
TCGA-10-0927-01A
0 years, female, stage:Stage IIIC, dead, 2490 days
7.8
TCGA-25-2400-01A
0 years, female, white, stage:Stage IIIC, dead, 1278 days
7.7
TCGA-13-0768-01A
0 years, female, white, stage:Stage IIIC, dead, 1784 days
7.7
TCGA-29-1781-01A
0 years, female, white, stage:Stage IIIC, alive, 255 days
7.6
TCGA-36-1570-01A
0 years, female, white, stage:Stage IIIC, alive, 655 days
7.6
TCGA-13-0887-01A
0 years, female, white, stage:Stage IIIC, dead, 2028 days
7.5
TCGA-24-1930-01A
0 years, female, white, stage:Stage IIIC, dead, 2467 days
7.5
TCGA-04-1341-01A
0 years, female, white, stage:'--, alive, 33 days
7.4
TCGA-13-0727-01A
0 years, female, white, stage:Stage IIIC, dead, 462 days
7.4
TCGA-23-1113-01A
0 years, female, white, stage:Stage IV, dead, 949 days
7.4
TCGA-29-1774-01A
0 years, female, white, stage:Stage IIIC, alive, 527 days
7.3
TCGA-04-1332-01A
0 years, female, white, stage:Stage IIIC, dead, 1247 days
7.3
TCGA-29-1777-01A
0 years, female, white, stage:Stage IIIC, alive, 374 days
7.3
TCGA-59-2352-01A
0 years, female, white, stage:Stage IIIC, dead, 286 days
7.3
TCGA-13-0886-01A
0 years, female, white, stage:Stage IIIC, alive, 4665 days
7.3
TCGA-24-1104-01A
0 years, female, white, stage:Stage IV, dead, 1933 days
7.2
TCGA-04-1350-01A
0 years, female, white, stage:Stage IIIC, dead, 1946 days
7.1
TCGA-24-1565-01A
0 years, female, white, stage:Stage IIIC, dead, 312 days
7.1
TCGA-24-1544-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 820 days
7.0
TCGA-29-2414-01A
0 years, female, white, stage:Stage IIIC, dead, 2621 days
7.0
TCGA-29-1769-01A
0 years, female, white, stage:Stage IIIC, alive, 699 days
7.0
TCGA-23-1119-01A
0 years, female, white, stage:Stage IIIC, alive, 3953 days
7.0
TCGA-04-1651-01A
0 years, female, white, stage:Stage IIIC, dead, 1102 days
6.9
TCGA-04-1347-01A
0 years, female, white, stage:Stage IV, alive, 1919 days
6.9
TCGA-29-1778-01A
0 years, female, white, stage:Stage IIIC, alive, 454 days
6.9
TCGA-13-0714-01A
0 years, female, white, stage:Stage IV, dead, 189 days
6.9
TCGA-61-1910-01A
0 years, female, white, stage:Stage IIC, alive, 1127 days
6.8
TCGA-23-1122-01A
0 years, female, white, stage:Stage IIIC, dead, 1189 days
6.8
TCGA-57-1586-01A
0 years, female, white, stage:Stage IIIC, alive, 679 days
6.8
TCGA-13-0800-01A
0 years, female, white, stage:Stage IIIC, alive, 2661 days
6.7
TCGA-24-1471-01A
0 years, female, white, stage:Stage IIIC, alive, 36 days
6.7
TCGA-04-1530-01A
0 years, female, white, stage:Stage IIIC, dead, 3622 days
6.6
TCGA-13-0891-01A
0 years, female, white, stage:Stage IV, dead, 3128 days
6.6
TCGA-24-1413-01A
0 years, female, white, stage:Stage IIIC, alive, 192 days
6.6
TCGA-30-1866-01A
0 years, female, white, stage:Stage IV, dead, 1114 days
6.6
TCGA-13-1488-01A
0 years, female, white, stage:Stage IV, dead, 2154 days
6.6
TCGA-13-1510-01A
0 years, female, white, stage:Stage IIIC, dead, 1359 days
6.4
TCGA-10-0937-01A
0 years, female, white, stage:Stage IIIC, dead, 608 days
6.3
TCGA-23-1110-01A
0 years, female, white, stage:Stage IIIC, alive, 1658 days
6.2
TCGA-59-2363-01A
0 years, female, asian, stage:Stage IIIA, alive, 165 days
6.1
TCGA-04-1356-01A
0 years, female, white, stage:Stage IIC, dead, 1499 days
6.1
TCGA-13-0888-01A
0 years, female, white, stage:Stage IIIC, dead, 2811 days
6.1
TCGA-29-1784-01A
0 years, female, white, stage:Stage IIIC, alive, 163 days
6.0
TCGA-61-2092-01A
0 years, female, white, stage:Stage IIIC, alive, 1573 days
6.0
TCGA-30-1714-01A
0 years, female, white, stage:Stage IV, dead, 1158 days
5.8
TCGA-23-1107-01A
0 years, female, white, stage:Stage IV, dead, 9 days
5.7
TCGA-24-1616-01A
0 years, female, white, stage:Stage IIIC, dead, 1163 days
5.7
TCGA-04-1519-01A
0 years, female, stage:Stage IIIC, alive, 24 days
5.6
TCGA-13-1499-01A
0 years, female, white, stage:Stage IIIC, alive, 3500 days
5.5
TCGA-29-1688-01A
0 years, female, white, stage:Stage IIIC, dead, 2400 days
5.5
TCGA-59-2351-01A
0 years, female, white, stage:Stage IIIC, alive, 3532 days
5.5
TCGA-VG-A8LO-01A
0 years, female, black or african american, stage:Stage IV, dead, 24 days
5.4
TCGA-13-1409-01A
0 years, female, white, stage:Stage IIIC, dead, 1742 days
5.3
TCGA-04-1536-01A
0 years, female, black or african american, stage:Stage IV, dead, 885 days
5.3
TCGA-09-1666-01A
0 years, female, white, stage:Stage IIIC, alive, 1752 days
5.3
TCGA-20-1686-01A
0 years, female, white, stage:Stage IIIC, alive, 89 days
5.2
TCGA-29-1766-01A
0 years, female, white, stage:Stage IIIC, dead, 1199 days
5.1
TCGA-57-1583-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 346 days
5.1
TCGA-13-1487-01A
0 years, female, white, stage:Stage IV, dead, 681 days
5.0
TCGA-24-0982-01A
0 years, female, white, stage:Stage IIIC, dead, 679 days
4.5
TCGA-10-0928-01A
0 years, female, white, stage:Stage IIIC, dead, 563 days
4.2
TCGA-13-0906-01A
0 years, female, white, stage:Stage IIIC, alive, 3619 days
4.1
TCGA-04-1338-01A
0 years, female, white, stage:Stage IIIC, alive, 1418 days
4.1
TCGA-30-1718-01A
0 years, female, white, stage:Stage IIIC, dead, 1579 days
4.1
TCGA-OY-A56Q-01A
0 years, female, black or african american, stage:Stage IIA, alive, 576 days
4.0
TCGA-61-1738-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 1089 days
4.0
TCGA-24-1845-01A
0 years, female, white, stage:Stage IIIC, alive, 116 days
4.0
TCGA-WR-A838-01A
0 years, female, black or african american, stage:Stage IIIC, dead, 304 days
4.0
TCGA-10-0931-01A
0 years, female, white, stage:Stage IIIC, dead, 1000 days
3.9
TCGA-10-0933-01A
0 years, female, white, stage:Stage IIIC, dead, 446 days
3.5
TCGA-13-1501-01A
0 years, female, white, stage:Stage IV, dead, 1314 days
3.5
TCGA-13-0724-01A
0 years, female, white, stage:Stage IV, dead, 83 days
3.4
TCGA-13-A5FT-01A
0 years, female, black or african american, stage:Stage IIIC, alive, 2143 days
3.4
TCGA-23-1022-01A
0 years, female, white, stage:Stage IIIC, dead, 1511 days
3.4
TCGA-10-0938-01A
0 years, female, white, stage:Stage IIIC, dead, 636 days
3.2
TCGA-30-1892-01A
0 years, female, white, stage:Stage IIIC, dead, 1484 days
3.0
TCGA-13-0762-01A
0 years, female, white, stage:Stage IIIC, alive, 3400 days
2.9
TCGA-23-1028-01A
0 years, female, white, stage:Stage IIIC, alive, 1503 days
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
SNX8 is not prognostic in Ovary Serous Cystadenocarcinoma (validation)
Stage:
Survival analysis
Current cut offi
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
:
Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A
P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A
5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average TPM
14.4
Number of samples
81
Samples
Sample
Description
TPM
DO46400
0 years, female, NA, stage:III, dead, 719 days
43.0
DO46348
0 years, female, NA, stage:IV, dead, 287 days
40.0
DO46350
0 years, female, NA, stage:III, dead, 886 days
31.1
DO46366
0 years, female, NA, stage:III, dead, 2054 days
30.9
DO46327
0 years, female, NA, stage:III, dead, 184 days
30.2
DO46551
0 years, female, NA, stage:III, dead, 1055 days
29.9
DO46576
0 years, female, NA, stage:III, alive, 133 days
27.5
DO46398
0 years, female, NA, stage:III, alive, 437 days
24.2
DO46611
0 years, female, NA, stage:III, dead, 734 days
24.0
DO46333
0 years, female, NA, stage:III, dead, 359 days
23.5
DO46368
0 years, female, NA, stage:III, dead, 2879 days
22.3
DO46356
0 years, female, NA, stage:III, dead, 911 days
22.3
DO46546
0 years, female, NA, stage:III, dead, 1889 days
21.3
DO46591
0 years, female, NA, stage:III, dead, 195 days
20.9
DO46358
0 years, female, NA, stage:III, dead, 423 days
20.8
DO46330
0 years, female, NA, stage:III, dead, 684 days
20.0
DO46340
0 years, female, NA, stage:III, dead, 616 days
19.5
DO46354
0 years, female, NA, stage:III, dead, 843 days
19.2
DO46342
0 years, female, NA, stage:III, dead, 1398 days
18.8
DO46346
0 years, female, NA, stage:III, dead, 1187 days
17.8
DO46331
0 years, female, NA, stage:III, dead, 612 days
17.7
DO46352
0 years, female, NA, stage:III, dead, 677 days
17.6
DO46382
0 years, female, NA, stage:IV, dead, 311 days
17.2
DO46378
0 years, female, NA, stage:III, alive, 843 days
17.1
DO46518
0 years, female, NA, stage:III, alive, 2960 days
16.6
DO46376
0 years, female, NA, stage:III, dead, 1430 days
16.4
DO46374
0 years, female, NA, stage:III, dead, 1409 days
15.7
DO46329
0 years, female, NA, stage:III, dead, 1699 days
15.4
DO46402
0 years, female, NA, stage:III, dead, 511 days
15.4
DO46344
0 years, female, NA, stage:III, dead, 642 days
15.3
DO46453
0 years, female, NA, stage:III, dead, 3294 days
15.1
DO46334
0 years, female, NA, stage:III, dead, 496 days
15.1
DO46326
0 years, female, NA, stage:III, dead, 701 days
14.7
DO46432
0 years, female, NA, stage:III, alive, 2218 days
14.5
DO46568
0 years, female, NA, stage:III, dead, 320 days
14.2
DO46428
0 years, female, NA, stage:IV, alive, 2644 days
13.0
DO46396
0 years, female, NA, stage:III, dead, 583 days
12.6
DO46362
0 years, female, NA, stage:III, dead, 1639 days
12.6
DO46528
0 years, female, NA, stage:III, alive, 6139 days
12.5
DO46538
0 years, female, NA, stage:III, dead, 1527 days
12.2
DO46332
0 years, female, NA, stage:III, dead, 689 days
12.0
DO46508
0 years, female, NA, stage:III, dead, 2101 days
12.0
DO46436
0 years, female, NA, stage:III, alive, 3193 days
11.3
DO46336
0 years, female, NA, stage:IV, dead, 664 days
11.2
DO46581
0 years, female, NA, stage:III, dead, 408 days
11.1
DO46412
0 years, female, NA, stage:III, dead, 597 days
10.8
DO46404
0 years, female, NA, stage:III, dead, 690 days
10.6
DO46388
0 years, female, NA, stage:III, dead, 413 days
10.6
DO46386
0 years, female, NA, stage:III, dead, 1162 days
10.6
DO46392
0 years, female, NA, stage:III, dead, 628 days
10.5
DO46602
0 years, female, NA, stage:III, dead, 205 days
10.5
DO46493
0 years, female, NA, stage:IV, alive, 839 days
10.4
DO46597
0 years, female, NA, stage:III, dead, 393 days
10.3
DO46380
0 years, female, NA, stage:III, dead, 1423 days
10.3
DO46443
0 years, female, NA, stage:III, dead, 2464 days
10.2
DO46384
0 years, female, NA, stage:III, dead, 614 days
10.1
DO46448
0 years, female, NA, stage:III, dead, 654 days
10.0
DO46533
0 years, female, NA, stage:III, alive, 3667 days
9.8
DO46364
0 years, female, NA, stage:III, dead, 806 days
9.8
DO46586
0 years, female, NA, stage:III, dead, 1019 days
9.7
DO46338
0 years, female, NA, stage:III, dead, 596 days
9.4
DO46360
0 years, female, NA, stage:IV, dead, 1759 days
9.3
DO46325
0 years, female, NA, stage:III, dead, 477 days
9.2
DO46566
0 years, female, NA, stage:III, dead, 673 days
8.7
DO46606
0 years, female, NA, stage:III, alive, 804 days
8.7
DO46571
0 years, female, NA, stage:III, dead, 243 days
8.7
DO46408
0 years, female, NA, stage:III, dead, 489 days
8.3
DO46588
0 years, female, NA, stage:III, dead, 438 days
7.9
DO46438
0 years, female, NA, stage:IV, alive, 2227 days
7.6
DO46463
0 years, female, NA, stage:III, dead, 2451 days
7.5
DO46390
0 years, female, NA, stage:III, dead, 374 days
6.8
DO46560
0 years, female, NA, stage:IV, dead, 286 days
6.8
DO46523
0 years, female, NA, stage:IV, alive, 1873 days
6.7
DO46513
0 years, female, NA, stage:IV, dead, 1883 days
6.5
DO46468
0 years, female, NA, stage:III, alive, 2776 days
6.5
DO46394
0 years, female, NA, stage:IV, dead, 1039 days
6.2
DO46458
0 years, female, NA, stage:IV, alive, 3787 days
6.1
DO46372
0 years, female, NA, stage:III, dead, 1326 days
5.7
DO46370
0 years, female, NA, stage:III, dead, 1727 days
5.3
DO46328
0 years, female, NA, stage:III, dead, 972 days
5.0
DO46561
0 years, female, NA, stage:III, dead, 195 days
3.7
Show allShow less
OVARY SEROUS CYSTADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
108
Samples
Sample ID
Sample type
nRPX
42d860a3-8a0c-4c44-a09a-9ad8cf_D2
Tumor
0.5
49bd51fe-48a1-4828-b66e-b30c38_D2
Tumor
0.3
fbb41c94-aabd-49cc-90b2-882c3e_D2
Tumor
0.3
3e746bea-ed68-40e6-b348-6ddf08_D2
Normal
0.2
cfd76f9a-ce60-4ec7-8e6b-a8fc31_D3
Tumor
0.2
8e17b45e-6a06-4e4e-913d-7b1edb_D2
Tumor
0.0
6530147a-efe9-4df6-ac2f-03ece3_D2
Tumor
0.0
b22659b9-e12c-4725-a7db-a833de_D1_D2
Normal
0.0
05387aad-2a1f-42c2-8d6f-950598_D3
Tumor
0.0
e3ebe010-cd31-4b5d-8fcb-b7103b_D2
Tumor
0.0
9a7a86d3-bbf2-4d36-941d-c75c03_D1_D2
Tumor
-0.1
35a345a4-e954-4c81-ae3f-7797cd_D2
Tumor
-0.1
9c8e78bf-b03e-4ba0-9909-5ff070_D2
Tumor
-0.1
7069e990-4a4e-4984-a66d-4d835a_D2
Tumor
-0.1
bd266bdd-12e4-42cb-9c49-911bfc_D2
Tumor
-0.1
0c87932d-b6fd-4eb5-b86a-a34d07_D2
Tumor
-0.1
e23eb014-69c1-460a-b9d4-9786c8_D2
Normal
-0.1
627e6e36-3dca-4ee5-9755-6f3510_D2
Tumor
-0.1
b9c1f22e-61f7-45ed-b3b4-5094c7_D2
Normal
-0.2
ce1e5dfc-2ef1-4633-af93-5ea4d9_D2
Tumor
-0.2
27f3ca2d-a86f-479d-8e7e-5307c7_D2
Tumor
-0.2
46c73531-f531-4ec3-97fe-b39d9d_D2
Tumor
-0.2
3d3e1888-d67e-4c69-ba83-112d0f_D2
Tumor
-0.2
256ac9f5-1e19-44b4-92fb-fef3fc_D2
Tumor
-0.2
69d552be-7cb2-4bb4-b602-a27b3e_D2
Tumor
-0.2
3490835c-c004-45ed-91f3-7c206f_D2
Tumor
-0.3
1772e913-f62e-446a-8cf3-720348_D2
Tumor
-0.3
51a4ce2f-4166-4c6b-a7e0-942d0a_D2
Tumor
-0.3
08296da7-70ea-44df-8646-09f2cc_D2
Tumor
-0.3
9e0d47e0-f633-468b-b82b-4d752d_D2
Tumor
-0.3
0745488e-0bfb-4d1f-8228-dedf76_D1_D2
Normal
-0.4
285fed94-1495-448e-879b-b55de9_D2
Tumor
-0.4
1c9145ad-1981-4871-aa7e-8b11de_D2
Tumor
-0.4
8234f8ea-bdbd-45b0-bd0b-16f1e7_D2
Tumor
-0.4
7c7ce2d7-6c8a-424e-8e6c-d14ad1_D2
Tumor
-0.4
8ed739dd-ae0f-4881-971a-db3cf4_D1_D2
Normal
-0.4
4ccb249a-6722-491e-97e9-e3b4e7_D2
Tumor
-0.4
6e209757-a7f4-45af-b5f3-2ebc02_D2
Normal
-0.4
31c15e30-21d4-4843-bd4a-9cd0d8_D2
Normal
-0.4
092af714-b97a-457c-b0e9-8c20e8_D2
Normal
-0.4
6319b36b-533c-4e86-8e12-80552e_D3
Tumor
-0.5
af95e2c6-25c4-4ab8-bf06-3e15ff_D2
Tumor
-0.5
a3a26070-fb84-406a-8280-d555e6_D2
Normal
-0.5
50997c44-1c8b-4d34-b535-4a6cc2_D2
Tumor
-0.5
340a3769-3031-41ae-bb08-a2f696_D2
Normal
-0.5
161317f3-1a39-438e-af45-cd2502_D2
Tumor
-0.5
15524912-685a-47ce-a824-567848_D2
Tumor
-0.5
62f5840e-6cd7-4200-b651-645e53_D2
Tumor
-0.5
5ea22f5e-307b-491d-801f-8b7fa6_D2
Tumor
-0.5
61f76fe6-a1c6-41b8-bdc2-2f9209_D2
Normal
-0.5
52c064a7-78d9-4a1a-85b4-27c6d1_D2
Tumor
-0.6
7edfd606-4bee-4529-9fec-1ca7f0_D2
Normal
-0.6
3fbf076a-824b-4eac-b6dc-bf5e59_D2
Normal
-0.6
1abbcb28-f221-4cd4-8c01-37b9bb_D1_D2
Normal
-0.6
e7b656bf-3c34-4ba1-bdf3-c7eefe_D2
Tumor
-0.6
1de8d3d8-fc0e-4be0-8aa7-127c7b_D2
Tumor
-0.6
0cc794c3-5bf5-4621-b238-58a0f6_D2
Tumor
-0.6
a8853382-b726-4ce8-98d5-ca89df_D2
Tumor
-0.6
79b60f32-6cca-4cb6-9a1e-22a3ac_D2
Tumor
-0.7
3946a96c-e0ae-442f-83b4-a9350e_D2
Tumor
-0.7
51c1c79e-5a8e-4b0a-bf92-1c0cab_D2
Tumor
-0.7
1556af7e-c2ae-4fce-9aae-87c459_D1_D2
Normal
-0.7
10c2d629-0287-4511-ac25-f29031_D2
Tumor
-0.7
1db5574d-aca7-403c-8100-6e705f_D2
Normal
-0.7
2ed8beb2-bc63-4bad-b5fe-1916a0_D2
Tumor
-0.7
558333b0-ea23-4303-9e3c-4932b1_D2
Tumor
-0.7
91b287fd-eadb-442d-abcd-20b741_D2
Tumor
-0.7
347e379b-77c0-4dd3-aa25-18c9d1_D2
Tumor
-0.7
fe83e13f-9754-403b-8f74-d6caf8_D2
Tumor
-0.7
a583d3ff-8165-43e9-b764-23b7ef_D1_D2
Normal
-0.7
c17b0ff9-9057-4848-a0cc-abb25f_D2
Tumor
-0.7
76e77c6b-c80e-4391-bdbb-e1dcea_D2
Tumor
-0.7
2433b136-fc7b-4cea-b958-bc6efb_D2
Tumor
-0.7
1a10c200-3895-4648-b951-94f99f_D2
Tumor
-0.7
9b90eb78-2f50-4aeb-b010-d642f9_D2
Tumor
-0.8
a65d8e76-640f-4341-a561-afbb57_D2
Normal
-0.8
28d0abdb-f682-4bd3-9425-a9c508_D2
Tumor
-0.8
f6c215ea-5381-4521-bb61-be8e97_D2
Tumor
-0.8
2f901c90-617e-46da-9fac-d68369_D2
Tumor
-0.8
2115808b-6a0d-49bc-a8d7-b83bde_D2
Tumor
-0.8
74a45e5a-a35a-4c60-a4b4-f3f5ea_D2
Tumor
-0.9
41d0619e-b299-42e2-ac32-29e784_D2
Tumor
-0.9
e6850782-fd2a-4c53-b682-1852fe_D2
Tumor
-0.9
994f9b8e-46cb-413f-8ec8-2c2fed_D2
Normal
-0.9
7d953d1d-84b6-4ecd-b1d7-1ed865_D2
Tumor
-0.9
d4791079-c826-4fc7-9d9b-ee20ba_D2
Tumor
-0.9
a03d1103-b809-42c4-ad5c-5aff58_D2
Tumor
-0.9
8d78194e-fbef-4819-a7b5-b73ae9_D2
Tumor
-0.9
efc971f8-54c5-4531-a792-705ecf_D2
Tumor
-1.0
3dcf8b3c-c0c5-4dfa-9543-5d30fb_D2
Tumor
-1.0
2dc28da8-7ff1-4b9b-b5bd-17cc25_D2
Tumor
-1.1
3a380577-c134-47ba-a1ce-988d7c_D2
Tumor
-1.1
2563cb02-d58a-4286-8634-7502cd_D2
Tumor
-1.1
eb0a53df-7620-4024-8d2d-051142_D2
Tumor
-1.1
80873a0c-1f40-4d51-bab1-3f2071_D2
Tumor
-1.1
2b73e01c-347a-4dae-a71d-752aeb_D2
Normal
-1.2
21efd60f-6a31-4b98-9477-16a905_D2
Normal
-1.2
685ec3c2-e67a-40d3-9eb3-aa01c9_D1_D2
Normal
-1.2
927f0958-db5a-4bc5-92b7-2a3695_D2
Tumor
-1.2
d38f40fb-dd78-43b2-8b7b-4b6977_D2
Tumor
-1.3
eb3f3494-7057-4afe-b212-e6e9a3_D2
Tumor
-1.3
318d53c3-216b-4de1-a098-77d6dd_D2
Tumor
-1.4
2224c03f-b7b1-4368-887e-2b4cdf_D2
Tumor
-1.4
1b2ab076-c72f-4bbe-b9f9-657d24_D2
Tumor
-1.5
e9d416e7-f661-400a-896e-388545_D2
Tumor
-1.5
5c3971ee-87c7-4dff-b66e-f18892_D2
Tumor
-1.5
d109a3c0-350e-47f5-bda0-61899c_D2
Tumor
-1.6
2b4ce90c-8036-4207-ac3e-54a76f_D2
Tumor
-1.7
Show allShow less
OVARIAN CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.
The Human Protein Atlas project is funded
